General form of registration statement for all companies including face-amount certificate companies

Note 5 - Cash, Cash Equivalents and Investments - Cash Equivalents and Investments Carried at Fair Value (Details)

v3.24.4
Note 5 - Cash, Cash Equivalents and Investments - Cash Equivalents and Investments Carried at Fair Value (Details) - Pieris Pharmaceuticals, Inc. [Member] - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash equivalents $ 11,893    
Fair Value   $ 8,970  
Total   22,194 $ 38,152
Fair Value, Inputs, Level 1 [Member]      
Cash equivalents 11,893    
Total   22,194 22,087
Fair Value, Inputs, Level 2 [Member]      
Cash equivalents 0    
Total   0 16,065
Fair Value, Inputs, Level 3 [Member]      
Cash equivalents 0    
Total   0 0
Money Market Funds [Member]      
Cash equivalents 11,893 13,224 17,618
Money Market Funds [Member] | Fair Value, Inputs, Level 1 [Member]      
Cash equivalents 11,893 13,224 17,618
Money Market Funds [Member] | Fair Value, Inputs, Level 2 [Member]      
Cash equivalents 0 0 0
Money Market Funds [Member] | Fair Value, Inputs, Level 3 [Member]      
Cash equivalents $ 0 0 0
US Treasury Securities [Member]      
Fair Value   8,970 3,573
US Treasury Securities [Member] | Fair Value, Inputs, Level 1 [Member]      
Fair Value   8,970 3,573
US Treasury Securities [Member] | Fair Value, Inputs, Level 2 [Member]      
Fair Value   0 0
US Treasury Securities [Member] | Fair Value, Inputs, Level 3 [Member]      
Fair Value   $ 0 $ 0